Navigation Links
Weifang Shengtai Purchased MVR Evaporator for Energy and Cost Saving
Date:8/5/2010

WEIFANG, Shandong, China, Aug. 6 /PRNewswire-Asia-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) announced today that on August 3, 2010, Weifang Shengtai Pharmaceutical Co., Ltd ("Weifang Shengtai"), its operating subsidiary in China, entered into an agreement with Jiangsu Zongheng Drying Equipment Co., Ltd. ("Jiangsu Zongheng") to purchase a 30T/MVR Glucose Evaporator ("the MVR Evaporator") that will help reduce total energy consumption and enhance production efficiency at Weifang Shengtai.

The MVR Evaporator consists of an automatic control system and other highly efficient parts and structures. While it consumes more electricity, it will consume less steam and in net, will reduce total costs in the process of evaporation. According to the Exchange rate on August 3, it will cost Weifang Shengtai 1.7 million USD to purchase and install the MVR Evaporator. The total cost of 1.70 USD includes the contract purchase prices of 1.55 million USD and the purchase price of 0.15 million USD of the accessories. Recognizing the MVR Evaporator as a major energy-saving project, the National Development and Reform Commission of the Chinese Central Government will award Weifang Shengtai 0.53 million USD in a one-time payment, as a result, the total costs of the MVR Evaporator project will reduce to 1.17 million USD, which in turn will be fully recovered by the operational cost saving within a year after the MVR evaporator is fully operational in production.

The MVR Evaporator is one of the projects that Weifang Shengtai is committed to in removing bottlenecks identified in production process, exploring of potential production capacity and cost reduction. Shengtai Pharmaceutical, Inc. will continue to communicate to investors the development of Weifang Shengtai's commitment to exploring of potential production capacity, cost reduction and enhancement of production efficiency. With smooth operation at Weifang Shengtai and the rebound of the selling prices of Weifang Shengtai's products after the financial crisis, Shengtai Pharmaceutical, Inc. is confident of its plans that will deliver returns to investors.

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly owned subsidiary, Shengtai Holding, Inc. (SHI), and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a manufacturer and distributor in China of glucose and starch products as pharmaceutical raw materials, other starch products and other glucose products such as corn meals, food and beverage glucose and dextrin. For more information about Shengtai Pharmaceutical, Inc., please visit http://www.shengtaipharmaceutical.com/ .

Forward Looking Statements

Certain statements in this press release and oral statements made by the Company constitute forward-looking statements concerning the Company's business and products. These statements include, without limitation, statements regarding our ability to prepare the Company for growth, the Company's planned capacity expansion and predictions and guidance relating to the Company's future financial performance. We have based these forward- looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs, but they involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand especially in the pharmaceutical industry, pricing and demand trends for the Company's products, changes to government regulations, risk associated with operation of the Company's new facilities, risk associated with large- scale implementation of the Company's business plan, the ability to attract new customers, ability to increase its product's applications, cost of raw materials, downturns in the Chinese economy, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. Investors are urged to consider these factors carefully in evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.

    For more information, please contact:

     Shengtai Pharmaceutical, Inc.
      Tel:   +86-536-629-5802
      Email: shengtaigsz@hotmail.com

     Investor Relations Contact
      DME Capital, LLC
      Mr. David M. Elias
      Tel:   +1-516-967-0205
      Email: dave@dmecapital.com


'/>"/>
SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Shengtai Pharmaceutical, Inc Announces Appointment of New Chief Financial Officer
2. Shengtai Pharmaceutical, Inc. Reports Financial Results for the Third Quarter and the First Nine Months of Fiscal Year 2010
3. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
4. Popular Energy Drinks Cause Tooth Erosion
5. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
6. September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging
7. SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts
8. July 2009 Mayo Clinic Womens HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
9. Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress
10. Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc.
11. Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... 2016  According to Kalorama Information, the world ... 2015.  Though these are challenging times in the ... success for companies that remain optimistic and seek ... growth prospects medical device companies spend a higher ... (R&D) than do companies in other industries.  Also, ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... , May 25, 2016 As ... Expo earlier this month, the numbers and momentum of ... to climb into the billions, more research and development ... 4th Edition State of Legal Marijuana Markets Report  from ... data-analysis firm, much of the increase in sector is ...
Breaking Medicine Technology:
(Date:5/25/2016)... TX (PRWEB) , ... May 25, 2016 , ... ... the United States, named Dr. Anh Tat Nguyen, as the Medical Director of its ... the facility Medical Director of our new DeSoto location,” said Dr. James M. Muzzarelli, ...
(Date:5/25/2016)... Secaucus, New Jersey (PRWEB) , ... May 25, 2016 , ... ... a specialized technology firm will be selling the device branded as Stern’s Real ... which is geared to bedbugs to the hotel and motel industry, colleges for use ...
(Date:5/24/2016)... ... May 24, 2016 , ... According to an article published May ... assigned to reduce the amount of calories they consumed by 25% experienced some interesting ... enjoyed better sleep, improved quality of life, and enhanced sexual function compared to the ...
(Date:5/24/2016)... ... 24, 2016 , ... BTC Media, a leading digital currency ... to be held in Nashville, Tennessee on September 7, 2016. , The conference ... the event will host teams from around the world, competing to build the ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... To better ... a new research award to examine gender differences in lung cancer. Today, the Lung ... Innovation Project: Lung Cancer in Women Award, funded by the American Lung Association’s LUNG ...
Breaking Medicine News(10 mins):